Behrens et al. (2009) have noted that whereas reduced P53 expression arising from mutations may lead to uncontrolled cell proliferation, as in colorectal cancer, osteosarcoma, and other tumors, increased P53 expression may activate pathways leading to cell death, such as occurs in AD. Here, TP53 is linked to osteosarcoma.